ro 22-1319 has been researched along with 3,3'-iminodipropionitrile in 1 studies
| Studies (ro 22-1319) | Trials (ro 22-1319) | Recent Studies (post-2010) (ro 22-1319) | Studies (3,3'-iminodipropionitrile) | Trials (3,3'-iminodipropionitrile) | Recent Studies (post-2010) (3,3'-iminodipropionitrile) |
|---|---|---|---|---|---|
| 23 | 3 | 0 | 235 | 0 | 35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, T; Cadet, JL; Freed, WJ | 1 |
1 other study(ies) available for ro 22-1319 and 3,3'-iminodipropionitrile
| Article | Year |
|---|---|
The dopamine D-2 antagonist, Ro 22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile (IDPN) in mice.
Topics: Animals; Isoquinolines; Male; Mice; Motor Activity; Nitriles; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior | 1987 |